5 citations,
July 2022 in “Journal of Clinical Medicine” Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.
4 citations,
October 2020 in “Research Square (Research Square)” Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.
4 citations,
October 2020 in “Research Square (Research Square)” Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.
3 citations,
May 2023 in “Frontiers in Public Health” Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.
3 citations,
May 2021 in “British Journal of Dermatology” The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.
2 citations,
July 2021 in “Dermatologic Therapy” A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.
1 citations,
December 2021 in “Medical Records” The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.
1 citations,
November 2021 in “F1000Research” The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.
1 citations,
May 2021 in “InterConf” Post-COVID-19 hair loss is likely due to stress and inflammation.
1 citations,
April 2021 in “Clinical and Experimental Dermatology” The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.
1 citations,
October 2020 in “Research Square (Research Square)” Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.
July 2024 in “Vestnik dermatologii i venerologii” Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.
Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.
June 2024 in “Research Square (Research Square)” Copper deficiency is linked to post-COVID-19 hair loss in women.
April 2024 in “The Egyptian Family Medicine Journal/The Egyptian Family Medicine Journal ” Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.
March 2024 in “Advancements in Homeopathic Research” Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.
February 2024 in “Psychoneuroendocrinology” The COVID-19 pandemic did not significantly change stress levels in preschoolers, but higher-income families' children showed higher stress.
December 2023 in “Damianus Journal of Medicine” Post-COVID-19 patients are at risk for hair loss.
December 2023 in “Y Dược học” Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.
April 2023 in “Journal of Investigative Dermatology” The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.
Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.
December 2022 in “Siriraj Medical Journal” The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.
November 2022 in “PubMed” The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.
July 2022 in “Hair transplant forum international” The COVID-19 pandemic affected hair restoration practices in 2022.
June 2022 in “Journal of the turkish academy of dermatology” The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.
May 2022 in “International Journal of Dermatology” A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.
A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.
Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.
December 2021 in “Turkderm” The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.
November 2021 in “Open Forum Infectious Diseases” Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.